N@N

Faruqi amp;; Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Chemed Corporation

_{//health-fitness.news-articles.net/content/2013/ .. -of-100-000-investing-in-chemed-corporation.html}
^{Published in Health and Fitness on Tuesday, May 7th 2013 at 13:45 GMT by Market Wire}  

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of... -- NEW YORK, May 7, 2013 /PRNewswire/ --

[ ]

[ Download image ]

NEW YORK, May 7, 2013 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Chemed Corporation ("Chemed" or the "Company") (NYSE: CHE).

(Logo: [ http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ] )

On May 2, 2013, the United States Department of Justice ("DOJ") filed a lawsuit against Chemed and its affiliates alleging that the Company had methodically defrauded the national Medicare program.  The DOJ action alleges that Chemed aggressively marketed "crisis care"—a type of intensive nursing care reserved for severely ill patients—to patients not needing it, and subsequently billed Medicare for the costs associated.  The DOJ action further alleges that the Company billed Medicare for crisis care for patients who never received it, billed Medicare for hospice care for patients who were not terminally ill, and submitted fraudulent records or statements in support of Chemed's Medicare claims.

The lawsuit includes claims under the federal False Claims Act.  If Chemed is found liable for these claims, the Company could be liable to pay back three times the amount of money it collected from Medicare as a result of the alleged fraud, plus thousands of dollars in penalty fees for each individual false claim submitted to the government.

On the day following the announcement of the DOJ's lawsuit, shares of Chemed fell nearly 20% in early trading, the Company's largest single-day share price decline in five years.

Request more information now by clicking here:  [ www.faruqilaw.com/CHE ].  There is no cost or obligation to you.

Take Action

If you invested in Chemed stock or options and would like to discuss your legal rights, visit [ www.faruqilaw.com/CHE ].  You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [ rgonnello@faruqilaw.com ] or [ fmcconville@faruqilaw.com.  ] Faruqi & Faruqi, LLP also encourages anyone with information regarding Chemed's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ([ www.faruqilaw.com ]).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
[ rgonnello@faruqilaw.com ] 
Francis McConville, Esq.
[ fmcconville@faruqilaw.com ] 
Telephone: (877) 247-4292 or (212) 983-9330

SOURCE Faruqi & Faruqi, LLP